- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Kronos Bio (NASDAQ:KRON), Quotes and News Summary
Kronos Bio (NASDAQ: KRON)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-11 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.650 | ||||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Kronos Bio Questions & Answers
You can purchase shares of Kronos Bio (NASDAQ: KRON) through any online brokerage.
Other companies in Kronos Bio’s space includes: Molecular Partners (NASDAQ:MOLN), AVEO Pharmaceuticals (NASDAQ:AVEO), Innate Pharma (NASDAQ:IPHA), Impel Pharmaceuticals (NASDAQ:IMPL) and Vaxxinity (NASDAQ:VAXX).
The latest price target for Kronos Bio (NASDAQ: KRON) was reported by Goldman Sachs on Tuesday, May 24, 2022. The analyst firm set a price target for 23.00 expecting KRON to rise to within 12 months (a possible 531.87% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Kronos Bio (NASDAQ: KRON) is $3.64 last updated June 30, 2022, 8:00 PM UTC.
There are no upcoming dividends for Kronos Bio.
Kronos Bio’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for Kronos Bio.
Kronos Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.